A research study published in the journal Neoplasia and led by principal investigator Nallasivam Palanisamy, Ph.D., associate scientist in the Vattikuti Urology Institute at Henry Ford Health System, has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene. This unique biomarker can be detected in the urine samples of patients with prostate cancer, offering a non-invasive means of detection.
from http://besthealthnews.com/2019/10/study-biomarker-in-urine-may-offer-noninvasive-detection-of-prostate-cancer/?utm_source=rss&utm_medium=rss&utm_campaign=study-biomarker-in-urine-may-offer-noninvasive-detection-of-prostate-cancer
from
https://healthnews010.tumblr.com/post/188100259583
No comments:
Post a Comment